Finished
Recurrence Patterns and Cost-Effectiveness of Surgical Approaches in Early-Stage Hepatocellular Carcinoma
NCT06776185 · Chen Xiaoping · Updated 15 Jan 2025
- What is being tested
- Liver Surgery
- For
- HCC - Hepatocellular Carcinoma
- Kind of study
- Watches patients without assigning a treatment. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years to 80 years. About 3,000 people. The full rules are on the registry page.
- Where
- China
- When
- Starts or started 15 Jan 2022, ends 15 Nov 2024. Registered 15 Jan 2025.
- Results
- None posted yet.
In the researchers' words
This study aims to investigate the recurrence patterns and cost-effectiveness of robotic-assisted, laparoscopic, and open liver resections in patients with early-stage (BCLC 0/A) hepatocellular carcinoma. By analyzing data from 3000 patients across 27 centers, the research evaluates recurrence-free survival, overall survival, and long-term economic impacts using metrics such as quality-adjusted life years (QALYs) and incremental cost-effectiveness ratios (ICERs). Findings will provide insights into optimal surgical approaches to improve patient outcomes and healthcare resource utilization.
Sites
- Wuhan Tongji HospitalWuhan, Hubei, China